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Congestive heart failure, the leading cause of morbidity 
and mortality worldwide, is characterized by the irrever-
sible loss of cardiac cells and function. Implantation of 
exogenous stem cells or activation of endogenous pro-
genitors holds great potential for the therapeutic re gen-
era tion of lost cardiomyocytes and supporting vascular 
cells [1]. With the progress in the fi eld, it is becoming 
evident that profound understanding of cardiac develop-
mental biology will be necessary for the discovery of cell 
types and conditions that can lead to successful cardiac 
repair.
Recently, epicardium of the heart has received a lot of 
attention as a potential source of cardiovascular pro-
genitors [2-4]. Traditionally, embryonic epicardium has 
been known for its paracrine roles in myocardial growth 
and diff erentiation and its contribution to cells of cardiac 
connective tissue and coronary vasculature [5]. Recent 
lineage tracing studies using epicardial markers Wt1 and 
Tbx18 have suggested that murine embryonic epicar-
dium-derived cells (EPDCs) can also diff erentiate into 
cardiomyocytes [2,3]. Unlike in the embryo, the epicardium 
in the healthy adult heart remains quiescent; however, 
upon myocardial infarction, it gives rise to new EPDCs 
that diff erentiate into mesenchymal cells expressing 
fi broblast and smooth muscle markers. Although EPDCs 
do not adopt cardiomyocyte or endothelial cell fate, they 
still secrete paracrine factors that strongly stimulate 
angiogenesis in subepicardial layers [6]. Interestingly, if 
the murine heart is preconditioned with thymosin β4 
(Tβ4) prior to infarction, the adult EPDCs can migrate 
into myocardium and give rise to new cardiomyocytes 
[4]. Unfortunately, in a clinically relevant scenario of Tβ4 
post-conditioning, the EPDCs remain in the thickened 
epicardium and do not attain cardiogenic fate [7].
In line with these exciting developments, Chong and 
colleagues [8] have recently reported a new type of 
mesen chymal stem cell of epicardial origin found in 
embryonic and adult mouse heart that, similar to mesen-
chymal stem cells from bone marrow (BM), can form 
clonal colonies and undergo a long-term expansion for 
approximately 40 passages. In the adult heart, these 
cardiac colony-forming-unit fi broblasts (cCFU-Fs) reside 
in a perivascular adventitial niche and can be isolated 
from the non-cardiomyocyte fraction of the heart based 
on the expression of the surface markers platelet-derived 
growth factor receptor-α and Sca-1. Th e cCFU-Fs lack 
expression of cKit, CD31, Flk1, CD45, Nkx2-5, NG2, and 
the pluripotency genes Rex1, Sox2, Klf4 and Nanog. 
Under optimized conditions, they diff er entiate in vitro
and in vivo into diff erent mesodermal lineages (for 
example, bone, cartilage, fat, smooth muscle, endo the-
lium, cardiomyocytes), and when co-trans planted with 
embryonic stem cells, also attain non-mesodermal fates 
(for example, liver, neuronal, lung epithelium). Under the 
5-aza-2’deoxycytidine treatment or in non-contact co-
cultures with neonatal rat cardio myocytes, 1 to 2% of the 
cCFU-Fs attain cardiac diff eren tiation markers, but 
despite some sarcomeric organiza tion, do not sponta-
neously contract, presumably due to paracrine inhibition 
by surrounding non-cardiomyocytes [8].
In the elegant Cre-recombinase lineage tracing studies, 
Chong and colleagues further show that cCFU-Fs 
originate from mesoderm (expressing Mesp1) but not 
from neural crest (expressing Wnt1) or cardiomyocytes 
(expressing Nkx2.5 and Myl2). Importantly, the use of the 
epicardial-specifi c Cre lineage tags Wt1 and Gata5 
showed that cCFU-Fs derive from proepicardium and 
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The clinical use of stem cells, such as bone marrow-
derived and, more recently, resident cardiac stem 
cells, off ers great promise for treatment of myocardial 
infarction and heart failure. The epicardium-derived 
cells have also attracted attention for their angiogenic 
paracrine actions and ability to diff erentiate into 
cardiomyocytes and vascular cells when activated 
during cardiac injury. In a recent study, Chong and 
colleagues have described a distinct population of 
epicardium-derived mesenchymal stem cells that 
reside in a perivascular niche of the heart and have a 
broad multilineage potential. Exploring the therapeutic 
capacity of these cells will be an exciting future 
endeavor.
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epicardium, and may be similar or hierarchically related 
to previously identifi ed EPDCs. In addition, the cCFU-Fs 
appear to be distinct from previously reported cKIT+ 
progenitors found in epicardium as these cells also 
expressed Nkx2-5 [9]. Th ey also appear mostly diff erent 
from pericytes based on no expression of NG2 or other 
pericyte markers.
In a previous study [10], the cCFU-Fs were found to be 
transcriptionally similar, but not identical, to BM CFU-
Fs, suggesting their similar early origins, but potentially 
diff erent tissue-specifi c functions. To investigate the 
potential contribution of BM cells to the cCFU-F com part-
ment, Chong and colleagues transplanted green fl uores-
cent protein (GFP)+ BM cells into lethally irradiated mice 
and examined their contribution to cCFU-F colonies 
after myocardial infarction and 2 to 8 months of aging. 
Th ey found that both cCFU-Fs and BM cells were 
irradiation-sensitive and while GFP+ BM cells were able 
to reestablish the niche for BM CFU-Fs, they failed under 
all conditions (including mobilization by granulocyte 
colony stimulat ing factor) to contribute to cCFU-Fs. Th e 
majority of GFP+ cells that entered the heart post-
myocardial infarc tion were cKit+/CD45+ but none formed 
cCFU-Fs, suggesting a distinct phenotype of cCFU-Fs 
from those of BM-derived cKit+ cells. Finally, none of the 
Wt1-, Gata5-, or Mesp1-tagged cells participated in the 
forma tion of BM cCFU-Fs, further suggesting distinct 
post-gastrulation origins of BM cells and cCFU-Fs.
Th e cutting-edge studies by Chong and colleagues open 
multiple avenues for future investigations to answer 
several important questions: are the cCFU-Fs solely 
derived from the epicardium, or does the endocardium 
contribute a fraction of these cells? How diff erent are 
these cells from other resident stem cells identifi ed in the 
adult heart [11]? How does aging aff ect frequency and 
potency of the cCFU-Fs? Do the endogenous cCFU-Fs 
diff erentiate into functional cardiomyocytes in vivo? If 
separated from the non-cardiomyocyte cCFU-F deriva-
tives (perhaps via an α-MHC driven tag), will the in vitro 
diff erentiated cardiomyocytes become electromechani-
cally active? Could the robust proliferative capacity of 
cCFU-Fs make them a good candidate for in vitro or in 
situ direct reprogramming to the cardiomyocyte fate 
using transcription factors [12] or microRNAs? Would 
priming these cells with Tβ4 enhance their cardiogenic 
potential? And most importantly, to what extent are these 
fi ndings from mice applicable to a human setting? 
Answer ing these questions may bring us a few steps 
closer to making cardiac regenerative therapies a reality.
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